CLOVER HEALTH INVESTMENTS, CORP. /DE Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $3.36 per share for the 12-month period ending 2021-12-31, per its 10-K filed 2024-03-14.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2024-03-14
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2021-03-31 was $3.36, a 84.62% increase year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for the quarter ending 2020-03-31 was $1.82.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2021 was $3.36, a 223.08% increase from fiscal 2020.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2020 was $1.04, a 67.74% increase from fiscal 2019.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2019 was $0.62.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month |
|---|---|---|---|---|
| 2021-12-31 | $3.36 10-K · filed 2024-03-14 | |||
| 2021-09-30 | $3.36 10-Q · filed 2022-11-07 | |||
| 2021-06-30 | $3.36 10-Q · filed 2022-08-08 | |||
| 2021-03-31 | $3.36 10-Q · filed 2022-05-09 | |||
| 2020-12-31 | $1.04 10-K · filed 2023-03-01 | |||
| 2020-09-30 | $2.10 10-Q · filed 2021-11-09 | |||
| 2020-06-30 | $1.83 10-Q · filed 2021-08-11 | |||
| 2020-03-31 | $1.82 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $0.62 10-K · filed 2022-02-28 |